JAZZ FY 2020 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$12B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.4B+9.3% YoY

Gross Profit

$2.2B93.7% margin

Operating Income

$378M16.0% margin

Net Income

$239M10.1% margin

EPS (Diluted)

$4.22

Cash Flow

Operating Cash Flow

$900M

Free Cash Flow

$520M

Stock-Based Comp.

$121M

Balance Sheet

Total Assets

$6.5B

Total Liabilities

$2.9B

Stockholders' Equity

$3.7B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.4B	$2.2B	+9.3%
Gross Profit	$2.2B	$2.0B	+8.9%
Operating Income	$378M	$532M	-29.0%
Net Income	$239M	$523M	-54.4%